You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NLRP3 Inflammasome

Showing 26 - 50 of 285
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metabolic Syndrome, Cardiovascular Risk Factor Trial in Athens (Probiotic mix, Placebo)

Withdrawn
  • Metabolic Syndrome
  • Cardiovascular Risk Factor
  • Probiotic mix
  • Placebo
  • Athens, Greece
    Attikon University General Hospital
Mar 30, 2022

Healthy Trial in Ahmedabad (ZYIL1 Capsule)

Completed
  • Healthy
  • ZYIL1 Capsule
  • Ahmedabad, Gujarat, India
    Zydus Research Centre
Nov 15, 2021

Mitochondrial Dysfunction in Occurrence of Acute Kidney Injury

Completed
  • Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
  • Coronary Artery Bypass Graft (CABG)
  • Fort-de-France, France
    CHU de Martinique
Feb 22, 2022

Mechanism for Exercise to Delay Cardiac Aging

Completed
  • Activity, Motor
  • Health Behavior
  • Vigorous intermittent lifestyle physical activity
  • Guangzhou, Guangdong, China
    Guangdong Pharmaceutical University
Sep 7, 2023

Myocardial Dysfunction, Heart Failure, Inflammation Trial run by the NHLBI (Dapagliflozin, MRI scan, CMR imaging)

Withdrawn
  • Myocardial Dysfunction
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 23, 2022

NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus

Unknown status
  • Escherichia Coli Infections
  • Staphylococcus Aureus
  • Sample analysis
  • Antibes, France
  • +2 more
Mar 7, 2019

IBD Trial (Atorvastatin 80mg, Mesalamine)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • (no location specified)
Oct 14, 2022

COVID-19 Pneumonia Trial in Doha (Colchicine)

Recruiting
  • COVID-19 Pneumonia
  • Doha, DA, Qatar
    Alaa Rahal
Nov 22, 2021

Healthy Trial in Ahmedabad (ZYIL1 capsule)

Completed
  • Healthy
  • ZYIL1 capsule
  • Ahmedabad, Gujarat, India
    Zydus Research Centre
Jun 16, 2021

Chronic Kidney Diseases, Peritoneal Dialysis, Hemodialysis Trial in Rio de Janeiro (Curcumin supplementation)

Recruiting
  • Chronic Kidney Diseases
  • +2 more
  • Curcumin supplementation
  • Rio de Janeiro, RJ, Brazil
    Denise Mafra
Jan 4, 2022

Role of NLRP3 in Periodontitis and Diabetes

Completed
  • Metabolic Disease
  • Periodontal Diseases
  • Observation of serum and salivary NLRP3 levels
  • Messina, Italy
    University of Messina
Jan 23, 2021

Drug Resistant Epilepsy Trial (Lactobacillus-Based Capsule)

Not yet recruiting
  • Drug Resistant Epilepsy
  • Lactobacillus-Based Capsule
  • (no location specified)
Sep 10, 2022

Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
Aug 1, 2023

Pregnancy Complications, Maternal Obesity Trial in Sultangazi (Biomarker measurement of pannexin-1 and gasdermin-D)

Completed
  • Pregnancy Complications
  • Maternal Obesity
  • Biomarker measurement of pannexin-1 and gasdermin-D
  • Sultangazi, İstanbul, Turkey
    Haseki Training and Research Hospital
Jul 25, 2022

Coronary Heart Disease, Clonal Hematopoiesis of Indeterminate Potential (CHIP) Trial (MAS825, MAS825 Placebo, DFV890)

Not yet recruiting
  • Coronary Heart Disease
  • Clonal Hematopoiesis of Indeterminate Potential (CHIP)
  • (no location specified)
Oct 24, 2023

Cryopyrin Associated Periodic Syndrome Trial in Adelaide (ZYIL1 capsule)

Completed
  • Cryopyrin Associated Periodic Syndrome
  • ZYIL1 capsule
  • Adelaide, Australia
    Department of Clinical Immunology and Allergy
Jul 8, 2022

Effect of Fasting on the Asthma Inflammasome

Completed
  • Asthma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 29, 2021

    Drug Resistant Epilepsy Trial (N-acetyl cysteine, Lactobacillus, Placebo)

    Not yet recruiting
    • Drug Resistant Epilepsy
    • N-acetyl cysteine
    • +2 more
    • (no location specified)
    Aug 2, 2022

    Hyperuricemia, Chronic Kidney Diseases Trial in Richmond (Allopurinol)

    Terminated
    Has Results
    • Hyperuricemia
    • Chronic Kidney Diseases
    • Richmond, Virginia
      Virginia Commonwealth University
    May 4, 2021

    Non-alcoholic Steatohepatitis Trial (Rosuvastatin 20mg, N-acetyl cysteine, Rosuvastatin and N-acetyl cysteine)

    Not yet recruiting
    • Non-alcoholic Steatohepatitis
    • Rosuvastatin 20mg
    • +3 more
    • (no location specified)
    Oct 29, 2023

    Non Alcoholic Steatohepatitis, Hyperuricemia Trial in Tanta (Febuxostat 80 MG Oral Tablet, vit E)

    Recruiting
    • Non Alcoholic Steatohepatitis
    • Hyperuricemia
    • Febuxostat 80 MG Oral Tablet
    • vit E
    • Tanta, Egypt
      Department of Tropical Medicine and Infectious Diseases, Faculty
    Oct 8, 2022

    Type 2 Diabetes, Inflammation, Insulin Sensitivity/Resistance Trial in Montréal (Omega-3 fatty acids)

    Recruiting
    • Type 2 Diabetes
    • +3 more
    • Omega-3 fatty acids
    • Montréal, Quebec, Canada
      Montreal Clinical Research Institute
    Aug 27, 2021

    Allergic Asthma Trial (House dust mite)

    Withdrawn
    • Allergic Asthma
    • House dust mite
    • (no location specified)
    Jul 27, 2021

    Obesity, Insulin Resistance, Inflammation Trial run by the Eunice Kennedy Shriver National Institute of Child Health and Human

    Recruiting
    • Obesity
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 16, 2022

    Acute Coronary Syndrome, Myocardial Ischemia Trial in Roma (Anamnesis and clinical evaluation)

    Recruiting
    • Acute Coronary Syndrome
    • Myocardial Ischemia
    • Anamnesis and clinical evaluation
    • Roma, Lazio, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS di R
    Mar 3, 2023